Tag: Department of Health – Abu Dhabi
UAE launches first genomics-driven clinical trial for Alzheimer’s
M42's Insights Research Organization and Solutions (IROS), in collaboration with the Department of Health – Abu Dhabi (DoH) and US-based Halia Therapeutics, has launched...
Abu Dhabi Biobank, BioTwin unite to advance AI in healthcare
The Abu Dhabi Biobank, a strategic initiative between the Department of Health-Abu Dhabi (DoH) and global health group M42, has partnered with BioTwin to...
Abu Dhabi DoH, Boehringer Ingelheim partner on genomics research
The Department of Health - Abu Dhabi (DoH) and global biopharmaceutical company Boehringer Ingelheim have signed a strategic collaboration to advance research into genetic...
M42, Arcera partner to boost biopharma in Abu Dhabi
M42 and Arcera Life Sciences (Arcera), a global life sciences company focused on innovative and sustainable healthcare solutions, have signed a Memorandum of Understanding...
Abu Dhabi DoH, Johnson & Johnson launch AI surgical network
The Department of Health - Abu Dhabi (DoH) has launched an emirate-wide intelligent surgical network in collaboration with Johnson & Johnson, marking what it...
Abu Dhabi Biobank, HLC Japan partner on stem cell therapies
Abu Dhabi Biobank has partnered with Human Life CORD Japan Inc (HLC) to localize the development and clinical application of umbilical cord–derived stem cell...
Abu Dhabi DoH rolls out obesity oral treatment with ADPHC
The Department of Health - Abu Dhabi (DoH) has introduced a new daily oral treatment option for obesity as part of its Personalised Weight...
M42, DoH Abu Dhabi study explores genetic risks in eye health
M42 has unveiled the results of a nationwide study conducted in partnership with the Department of Health – Abu Dhabi, showing that genomics can...
